Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Study of the Safety and Tolerability of IV Infused PG545 in Patients With Advanced Solid Tumours
- First Posted Date
- 2014-01-23
- Last Posted Date
- 2017-10-09
- Lead Sponsor
- Zucero Pty Ltd
- Target Recruit Count
- 23
- Registration Number
- NCT02042781
- Locations
- 🇦🇺
Nucleus Network Ltd, Melbourne, Victoria, Australia
🇦🇺Linear Clinical Research Ltd, Nedlands, Western Australia, Australia
Study of the Safety and Tolerability of PG545 in Patients With Advanced Solid Tumours
- First Posted Date
- 2010-12-02
- Last Posted Date
- 2017-10-09
- Lead Sponsor
- Zucero Pty Ltd
- Target Recruit Count
- 4
- Registration Number
- NCT01252095
- Locations
- 🇦🇺
Linear Clinical Research Ltd, Nedlands, Western Australia, Australia
News
No news found